Keeping Track: KemPharm Apadaz Delay; Cholera Vaccine Approved

The latest drug development news and highlights from our FDA Performance Tracker. Vaxchora cholera vaccine is CBER's fourth novel biologic cleared this year; Adamis emergency Epi turned down again.